5-HT1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex

Journal of Neurochemistry

Volumn 76, Issue 3, 2001, Pages 865-871

  Malagi, Isabelle ^a   Trillat, Anne Ccile ^a   Bourin, Michel ^b   Jacquot, Christian ^a   Hen, Ren ^c   Gardier, Alain M ^a,d  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITÉ DE NANTES   (France)

^d UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

5 hydroxytryptamine1B autoreceptors; Antidepressant drug; Intracerebral microdialysis; Knockout mice; Paroxetine; SSRIs

Indexed keywords

AUTORECEPTOR; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; PAROXETINE; RECEPTOR SUBTYPE; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT; OXADIAZOLE DERIVATIVE; PIPERAZINE DERIVATIVE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; HIPPOCAMPUS; MICRODIALYSIS; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SYNAPTOSOME; ANIMAL; DRUG COMBINATION; FRONTAL LOBE; GENETICS; MALE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; REFERENCE VALUE;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; AUTORECEPTORS; DRUG COMBINATIONS; FRONTAL LOBE; HIPPOCAMPUS; MALE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; OXADIAZOLES; PAROXETINE; PIPERAZINES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; REFERENCE VALUES; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0034746541     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00083.x     Document Type: Article

References (37)

1. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors
2. 1A antagonists
3. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: A double-blind, placebo-controlled trial
4. The use of pindolol with fluoxetine in the treatment of major depression: Final results from a double-blind, placebo-controlled trial
5. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression
6. 1B receptor is localized predominantly on axon terminals
7. 1A receptor antagonist
8. 1B binding sites
9. 1A receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT
10. 1B receptors with WAY 100635 and GR 127935
11. 1B sites
12. Effect of fluoxetine on extracellular 5-hydroxytryptamine. Role of 5-HT autoreceptors
13. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat
14. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study
15. Where are we going with SSRIs?
16. 1Dβ receptors in the rat, mouse and guinea pig with a specific anti-peptide antiserum
17. Absence of fenfluramine-induced anorexia and reduced c-fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knockout mice
18. Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: An in vivo microdialysis study
19. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: An in vivo microdialysis study
20. In vivo voltammetry in the suprachiasmatic nucleus of the rat: Effects of RU 24969, methiothepin and ketanserin
21. 1 receptor
22. GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test
23. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment
24. 1B knock-out mice
25. Species differences in 5-HT autoreceptors
26. 1B receptor knock-out behavioral consequences
27. 1A or 5-HT reuptake site blockade
28. 1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea-pig hypothalamus in vivo
29. 1A receptor antagonists in the dorsal raphe pathway: Role of somatodendritic autoreceptors
30. 1B receptor
31. 1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo
32. 1D receptor antagonist
33. Paroxetine and pindolol: A randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency
34. 1B receptors: In vivo microdialysis studies
35. How long should pindolol be associated with paroxetine to improve the antidepressant response?